To date our clinical trials have utilised healthy males and females, post menopausal women, elderly men and Type I and II diabetics. BioKinetic Europe has successfully completed studies for many international companies, covering a wide range of therapeutic areas.

Early Phase I and Proof of Concept are specific areas of expertise. We are keen to work collaboratively with your clinical research teams to design a programme of early Phase I studies best suited to your drugs’ needs.

We believe quality control is the key to early database lock. All studies are conducted to the most rigorous standards in accordance with the European Clinical Trials Directive and International Conference on Harmonisation Good Clinical Practice guidelines. Our Quality Assurance and Quality Control systems are models of best practice, ensuring exceptional accuracy and efficiency.

If you would like to learn more about our track record for excellence or how BioKinetic Europe services have helped our clients stay at the forefront, please contact us and we will provide information specific to your requirements. contact us